Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 3/2009

01-12-2009 | Short communication

Mammographic density

Authors: Norman F Boyd, Lisa J Martin, Martin Yaffe, Salomon Minkin

Published in: Breast Cancer Research | Special Issue 3/2009

Login to get access

Excerpt

The present short review will address three questions: What is the evidence that breast density is a major risk factor for breast cancer? How is breast density best assessed and what factors influence breast density? How do you utilize breast density in the preventative setting? …
Literature
1.
McCormack VA, dos Santos Silva I: Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1159-1169. 10.1158/1055-9965.EPI-06-0034.CrossRefPubMed
2.
Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ: Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007, 356: 227-236. 10.1056/NEJMoa062790.CrossRefPubMed
3.
Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo PG: A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States). Cancer Causes Control. 1995, 6: 431-438. 10.1007/BF00052183.CrossRefPubMed
4.
Saftlas AF, Hoover RN, Brinton LA, Szklo M, Olson DR, Salane M, Wolfe JN: Mammographic densities and risk of breast cancer. Cancer. 1991, 67: 2833-2838. 10.1002/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U.CrossRefPubMed
5.
Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R: Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst. 1995, 87: 1622-1629. 10.1093/jnci/87.21.1622.CrossRefPubMed
6.
Torres-Mejia G, De Stavola B, Allen D, Perez-Gavilan J, Ferreira J, Fentiman I, dos Santos Silva I: Mammographic features and subsequent risk of breast cancer: a comparison of qualitative and quantitative evaluations in the Guernsey prospective studies. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1052-1059. 10.1158/1055-9965.EPI-04-0717.CrossRefPubMed
7.
van Gils CH, Hendriks JH, Otten JD, Holland R, Verbeek AL: Parity and mammographic breast density in relation to breast cancer risk: indication of interaction. Eur J Cancer Prev. 2000, 9: 105-111. 10.1097/00008469-200004000-00006.CrossRefPubMed
8.
Thomas DB, Carter RA, Bush WH, Ray RM, Stanford JL, Lehman CD, Daling JR, Malone K, Davis S: Risk of subsequent breast cancer in relation to characteristics of screening mam-mograms from women less than 50 years of age. Cancer Epidemiol Biomarkers Prev. 2002, 11: 565-571.PubMed
9.
Maskarinec G, Pagano I, Lurie G, Kolonel LN: A longitudinal investigation of mammographic density: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev. 2006, 15: 732-739. 10.1158/1055-9965.EPI-05-0798.CrossRefPubMed
10.
Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ: Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995, 87: 670-675. 10.1093/jnci/87.9.670.CrossRefPubMed
11.
Sala E, Warren R, McCann J, Duffy S, Day N, Luben R: Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme. J Med Screen. 1998, 5: 207-212.CrossRefPubMed
12.
Wolfe JN: Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol. 1976, 126: 1130-1139.CrossRef
13.
Wolfe JN: Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer. 1976, 37: 2486-2492. 10.1002/1097-0142(197605)37:5<2486::AID-CNCR2820370542>3.0.CO;2-8.CrossRefPubMed
14.
15.
Jong R, Fishell E, Little L, Lockwood G, Boyd NF: Mammographic signs of potential relevance to breast cancer risk: the agreement of radiologists' classification. Eur J Cancer Prev. 1996, 5: 281-286. 10.1097/00008469-199608000-00008.CrossRefPubMed
16.
Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ: The quantitative analysis of mammographic densities. Phys Med Biol. 1994, 39: 1629-1638. 10.1088/0031-9155/39/10/008.CrossRefPubMed
17.
Kerlikowske K, Grady D, Barclay J, Frankel SD, Ominsky SH, Sickles EA, Ernster V: Variability and accuracy in mammographic interpretation using the American college of radiology breast imaging reporting and data system. J Natl Cancer Inst. 1998, 90: 1801-1809. 10.1093/jnci/90.23.1801.CrossRefPubMed
18.
Grove JS, Goodman MJ, Gilbert FI, Clyde D: Factors associated with breast structures in breast cancer patients. Cancer. 1979, 43: 1895-1899. 10.1002/1097-0142(197905)43:5<1895::AID-CNCR2820430546>3.0.CO;2-R.CrossRefPubMed
19.
Wolfe JN: Breast parenchymal patterns and their changes with age. Radiology. 1976, 121 (3 Pt 1): 545-552.CrossRefPubMed
20.
Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJ, Goode EL, Visscher DW: Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst. 2006, 98: 1600-1607. 10.1093/jnci/djj439.CrossRefPubMed
21.
Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG: 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature. 1983, 303: 767-770. 10.1038/303767a0.CrossRefPubMed
22.
Boyd NF, Lockwood GA, Byng J, Tritchler DL, Yaffe M: Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998, 7: 1133-1144.PubMed
23.
Martin LJ, Boyd N: Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res. 2008, 10: 1-14. 10.1186/bcr1831.CrossRef
24.
Vachon CM, Kuni CC, Anderson K: Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control. 2000, 11: 653-662. 10.1023/A:1008926607428.CrossRefPubMed
25.
Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M: A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev. 2002, 11 (10 Pt 1): 1048-1053.PubMed
26.
Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K: Mammographic breast density and family history of breast cancer. J Natl Cancer Inst. 2005, 95: 556-558.CrossRef
27.
Brisson J, Morrison AS, Kopans DB: Height and weight, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol. 1984, 119: 371-381.PubMed
28.
Grove JS, Goodman MJ, Gilbert F, Mi MP: Factors associated with mammographic pattern. Br J Radiol. 1985, 58: 21-25. 10.1259/0007-1285-58-685-21.CrossRefPubMed
29.
Sellers TA, Vachon CM, Pankratz VS, Janney CA, Fredericksen Z, Brandt KR, Huang Y, Couch FJ, Kushi LH, Cerhan JR: Association of childhood and adolescent anthropometric factors, physical activity, and diet with adult mammographic breast density. Am J Epidemiol. 2007, 166: 456-464. 10.1093/aje/kwm112.CrossRefPubMed
30.
Lawlor DA, Okasha M, Gunnell D, Smith GD, Ebrahim S: Associations of adult measures of childhood growth with breast cancer: findings from the British Women's Heart and Health Study. Br J Cancer. 2003, 89: 81-87. 10.1038/sj.bjc.6600972.CrossRefPubMedPubMedCentral
31.
Hunter DJ, Willett WC: Diet, body size, and breast cancer. Epidemiol Rev. 1993, 15: 110-132.PubMed
32.
Ekbom A: Growing evidence that several human cncers may originate in utero. Semin Cancer Biol. 1998, 8: 237-244. 10.1006/scbi.1998.0073.CrossRefPubMed
33.
Ekbom A, Thurfjell E, Hsieh CC, Trichopoulos D, Adami HO: Perinatal characteristics and adult mammographic patterns. Int J Cancer. 1995, 61: 177-180. 10.1002/ijc.2910610206.CrossRefPubMed
34.
Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A, WHI Investigators: Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. The Women's Health Initiative Randomized Trial. JAMA. 2003, 289: 3243-3253. 10.1001/jama.289.24.3243.CrossRefPubMed
35.
Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G: Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst. 2003, 95: 30-37. 10.1093/jnci/95.1.30.CrossRefPubMed
36.
Lundstrom E, Wilczek B, von Palffy Z, Soderqvist G, von Schoultz B: Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obstet Gynecol. 1999, 181: 348-352. 10.1016/S0002-9378(99)70560-0.CrossRefPubMed
37.
Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S: Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA. 2001, 285: 171-176. 10.1001/jama.285.2.171.CrossRefPubMed
38.
Cuzick J, Warwick J, Pinney E, Warren RML, Duffy SW: Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst. 2004, 96: 621-628. 10.1093/jnci/djh106.CrossRefPubMed
39.
Freedman M, San Martin J, O'Gorman J, Eckert S, Lippman ME, Lo SB, Walls EL, Zeng J: Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. J Natl Cancer Inst. 2001, 93: 51-56. 10.1093/jnci/93.1.51.CrossRefPubMed
40.
Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC: Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst. 1994, 86: 431-436. 10.1093/jnci/86.6.431.CrossRefPubMed
41.
Cuzick J, Warwick J, Pinney L, Warren R, Cawthorn S, Howell A, Duffy S: Change in breast density as a biomarker of breast cancer risk reduction [abstract]. Proc Natl Acad Sci USA. 2008, 0: 1-
42.
Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MRE, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, Hopper JL: Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med. 2002, 347: 886-894. 10.1056/NEJMoa013390.CrossRefPubMed
43.
Ursin G, Lillie EO, Lee E, Cockburn M, Schork NJ, Cozen W, Parisky YR, Hamilton AS, Astrahan MA, Mack T: The relative importance of genetics and environment on mammographic density. Cancer Epidemiol Biomarkers Prev. 2009, 18: 102-112. 10.1158/1055-9965.EPI-07-2857.CrossRefPubMed
44.
Freedman AN, Seminara D, Gail MH, Hartge P, Colditz GA, Ballard-Barbash R, Pfeiffer M: Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst. 2005, 97: 715-723. 10.1093/jnci/dji128.CrossRefPubMed
45.
Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S: Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007, 356: 2388-2398. 10.1056/NEJMsa053935.CrossRefPubMed
46.
Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989, 81: 1879-1886. 10.1093/jnci/81.24.1879.CrossRefPubMed
47.
48.
Colditz GA, Frazier LA: Models of breast cancer show that risk is set by events of early life: prevention efforts much shift focus [review]. Cancer Epidemiol Biomarkers Prev. 1995, 4: 567-571.PubMed
49.
Boyd NF, Martin LJ, Chavez S, Gunasekara A, Salleh A, Melnichouk O, Yaffe M, Minkin S, Bronskill MJ: Breast-tissue composition and other risk factors for breast cancer in young women: a cross-sectional study. Lancet Oncol. 2009, 10: 569-580. 10.1016/S1470-2045(09)70078-6.CrossRefPubMed
Metadata
Title
Mammographic density
Authors
Norman F Boyd
Lisa J Martin
Martin Yaffe
Salomon Minkin
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 3/2009
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2423

Other articles of this Special Issue 3/2009

Breast Cancer Research 3/2009 Go to the issue

Short communication

The role of preclinical animal models in breast cancer drug development

Short communication

Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors

Short communication

Tailored targeted therapy for all: a realistic and worthwhile objective against

Short communication

Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy?

Short communication

Underarm antiperspirants/deodorants and breast cancer

Short communication

Tailored targeted therapy for all: a realistic and worthwhile objective?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits